Innoviva (INVA) EBT Margin (2016 - 2025)
Historic EBT Margin for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to 90.74%.
- Innoviva's EBT Margin rose 830900.0% to 90.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 57.81%, marking a year-over-year increase of 546200.0%. This contributed to the annual value of 10.42% for FY2024, which is 521000.0% down from last year.
- Innoviva's EBT Margin amounted to 90.74% in Q3 2025, which was up 830900.0% from 72.39% recorded in Q2 2025.
- In the past 5 years, Innoviva's EBT Margin ranged from a high of 12141.74% in Q1 2021 and a low of 7859.27% during Q1 2025
- Its 5-year average for EBT Margin is 1526.99%, with a median of 125.87% in 2021.
- The largest annual percentage gain for Innoviva's EBT Margin in the last 5 years was 120211500bps (2021), contrasted with its biggest fall of -186190700bps (2021).
- Over the past 5 years, Innoviva's EBT Margin (Quarter) stood at 611.53% in 2021, then tumbled by -61bps to 982.68% in 2022, then soared by 56bps to 430.5% in 2023, then plummeted by -98bps to 853.36% in 2024, then skyrocketed by 111bps to 90.74% in 2025.
- Its last three reported values are 90.74% in Q3 2025, 72.39% for Q2 2025, and 7859.27% during Q1 2025.